A biotechnology and pharmaceutical company headquartered in San Francisco, California that was founded in 2016 by Charly Chahwan and Maria Soloveychik developing treatments for cancer and other diseases.
On April 20, 2017 SyntheX closed their seed funding round with $6.2 million in seed round funding from Morgan Noble, SOSV, Oriza Ventures, and 8VC.